Significant benefit of high-dose furmonertinib in the treatment of leptomeningeal metastases from non-small-cell lung cancer with EGFR ex19Del mutation: Two case reports and a literature reviewHuan Han, Hong Tang, Xiao Liu et al.|Research Square|2023Cited by 0